NAYA
Price
$2.03
Change
+$0.11 (+5.73%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
1.13M
VNDA
Price
$4.30
Change
-$0.03 (-0.69%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
257.17M
6 days until earnings call
Ad is loading...

NAYA vs VNDA

Header iconNAYA vs VNDA Comparison
Open Charts NAYA vs VNDABanner chart's image
NAYA Biosciences
Price$2.03
Change+$0.11 (+5.73%)
Volume$288
Capitalization1.13M
Vanda Pharmaceuticals
Price$4.30
Change-$0.03 (-0.69%)
Volume$25.71K
Capitalization257.17M
NAYA vs VNDA Comparison Chart
Loading...
NAYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NAYA vs. VNDA commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NAYA is a Hold and VNDA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (NAYA: $1.92 vs. VNDA: $4.33)
Brand notoriety: NAYA and VNDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NAYA: 493% vs. VNDA: 73%
Market capitalization -- NAYA: $1.13M vs. VNDA: $257.17M
NAYA [@Biotechnology] is valued at $1.13M. VNDA’s [@Biotechnology] market capitalization is $257.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NAYA’s FA Score shows that 0 FA rating(s) are green whileVNDA’s FA Score has 1 green FA rating(s).

  • NAYA’s FA Score: 0 green, 5 red.
  • VNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, NAYA is a better buy in the long-term than VNDA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NAYA’s TA Score shows that 4 TA indicator(s) are bullish while VNDA’s TA Score has 5 bullish TA indicator(s).

  • NAYA’s TA Score: 4 bullish, 3 bearish.
  • VNDA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, NAYA is a better buy in the short-term than VNDA.

Price Growth

NAYA (@Biotechnology) experienced а +4.35% price change this week, while VNDA (@Biotechnology) price change was -0.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

VNDA is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VNDA($257M) has a higher market cap than NAYA($1.13M). VNDA has higher P/E ratio than NAYA: VNDA (126.00) vs NAYA (1.30). VNDA YTD gains are higher at: -9.603 vs. NAYA (-80.247). NAYA has higher annual earnings (EBITDA): -5.58M vs. VNDA (-32.53M). VNDA has more cash in the bank: 375M vs. NAYA (472K). NAYA has less debt than VNDA: NAYA (5.34M) vs VNDA (12.4M). VNDA has higher revenues than NAYA: VNDA (199M) vs NAYA (6.23M).
NAYAVNDANAYA / VNDA
Capitalization1.13M257M0%
EBITDA-5.58M-32.53M17%
Gain YTD-80.247-9.603836%
P/E Ratio1.30126.001%
Revenue6.23M199M3%
Total Cash472K375M0%
Total Debt5.34M12.4M43%
FUNDAMENTALS RATINGS
NAYA vs VNDA: Fundamental Ratings
NAYA
VNDA
OUTLOOK RATING
1..100
687
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
84
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10091
PRICE GROWTH RATING
1..100
9757
P/E GROWTH RATING
1..100
362
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NAYA's Valuation (47) in the null industry is somewhat better than the same rating for VNDA (84) in the Biotechnology industry. This means that NAYA’s stock grew somewhat faster than VNDA’s over the last 12 months.

NAYA's Profit vs Risk Rating (100) in the null industry is in the same range as VNDA (100) in the Biotechnology industry. This means that NAYA’s stock grew similarly to VNDA’s over the last 12 months.

VNDA's SMR Rating (91) in the Biotechnology industry is in the same range as NAYA (100) in the null industry. This means that VNDA’s stock grew similarly to NAYA’s over the last 12 months.

VNDA's Price Growth Rating (57) in the Biotechnology industry is somewhat better than the same rating for NAYA (97) in the null industry. This means that VNDA’s stock grew somewhat faster than NAYA’s over the last 12 months.

VNDA's P/E Growth Rating (2) in the Biotechnology industry is somewhat better than the same rating for NAYA (36) in the null industry. This means that VNDA’s stock grew somewhat faster than NAYA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NAYAVNDA
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 11 days ago
83%
Bullish Trend 10 days ago
70%
Declines
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 4 days ago
70%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
76%
View a ticker or compare two or three
Ad is loading...
NAYA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GLDAX30.34N/A
N/A
Gabelli Gold A
TILGX24.06N/A
N/A
Nuveen Large Cap Growth R6
WSMDX23.16N/A
N/A
William Blair Small-Mid Cap Growth I
PMVEX22.22N/A
N/A
PGIM Quant Solutions Mid-Cap Val R2
PQJCX12.11N/A
N/A
PGIM Jennison Small-Cap Core Equity R6

NAYA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NAYA has been loosely correlated with VNDA. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if NAYA jumps, then VNDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NAYA
1D Price
Change %
NAYA100%
+6.67%
VNDA - NAYA
40%
Loosely correlated
-1.81%
RANI - NAYA
30%
Poorly correlated
+1.33%
TVGN - NAYA
26%
Poorly correlated
+5.25%
KPTI - NAYA
26%
Poorly correlated
+3.98%
SSKN - NAYA
25%
Poorly correlated
-3.15%
More

VNDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VNDA has been loosely correlated with AMLX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VNDA jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNDA
1D Price
Change %
VNDA100%
-1.81%
AMLX - VNDA
42%
Loosely correlated
+2.85%
NAYA - VNDA
40%
Loosely correlated
+6.67%
CLDX - VNDA
37%
Loosely correlated
+0.23%
GOSS - VNDA
37%
Loosely correlated
+7.51%
IKNA - VNDA
37%
Loosely correlated
+1.68%
More